Omid Farokhzad (file photo)
Seer raises $55M as proteomics approaches prime time in disease detection, drug development
Omid Farokhzad was working in his Harvard nanotech lab in 2017 when he found something he knew would become his next company. Two years and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
